Thus, we demonstrated a positive relationship between FLI1 expression and immune cell infiltration or immune cell biomarker expression in BRCA, which indicated that one of the reasons why patients with higher expression levels of FLI1 had a better prognosis might be the abundant activation of the immune process in the tumor environment. This evidence concerns the gene FLI1 and neoplasm.